Tezepelumab in Patients With Severe, Uncontrolled Asthma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Allergy, Asthma & Immunology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tezepelumab Improves Patient-Reported Outcomes in Patients With Severe, Uncontrolled Asthma in PATHWAY
Ann. Allergy Asthma Immunol. 2020 Oct 23;[EPub Ahead of Print], J Corren, E Garcia Gil, JM Griffiths, JR Parnes, R van der Merwe, K Sałapa, S O'QuinnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.